[go: up one dir, main page]

EP1261331A4 - METHODS AND COMPOSITIONS FOR THE TREATMENT OF FIBROTIC DISEASES - Google Patents

METHODS AND COMPOSITIONS FOR THE TREATMENT OF FIBROTIC DISEASES

Info

Publication number
EP1261331A4
EP1261331A4 EP01910707A EP01910707A EP1261331A4 EP 1261331 A4 EP1261331 A4 EP 1261331A4 EP 01910707 A EP01910707 A EP 01910707A EP 01910707 A EP01910707 A EP 01910707A EP 1261331 A4 EP1261331 A4 EP 1261331A4
Authority
EP
European Patent Office
Prior art keywords
compositions
treatment
methods
fibrotic diseases
fibrotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01910707A
Other languages
German (de)
French (fr)
Other versions
EP1261331A1 (en
Inventor
Steve I Rennard
Tadashi Kohyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nebraska Medical Center UNMC
Original Assignee
University of Nebraska Medical Center UNMC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nebraska Medical Center UNMC filed Critical University of Nebraska Medical Center UNMC
Publication of EP1261331A1 publication Critical patent/EP1261331A1/en
Publication of EP1261331A4 publication Critical patent/EP1261331A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP01910707A 2000-02-16 2001-02-15 METHODS AND COMPOSITIONS FOR THE TREATMENT OF FIBROTIC DISEASES Withdrawn EP1261331A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18287600P 2000-02-16 2000-02-16
US182876P 2000-02-16
US22762900P 2000-08-24 2000-08-24
US227629P 2000-08-24
PCT/US2001/004797 WO2001060358A1 (en) 2000-02-16 2001-02-15 Method and compositions for treating fibrotic diseases

Publications (2)

Publication Number Publication Date
EP1261331A1 EP1261331A1 (en) 2002-12-04
EP1261331A4 true EP1261331A4 (en) 2005-01-05

Family

ID=26878513

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01910707A Withdrawn EP1261331A4 (en) 2000-02-16 2001-02-15 METHODS AND COMPOSITIONS FOR THE TREATMENT OF FIBROTIC DISEASES

Country Status (4)

Country Link
EP (1) EP1261331A4 (en)
JP (1) JP2004502643A (en)
AU (1) AU2001238288A1 (en)
WO (1) WO2001060358A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
DK2020243T3 (en) * 2002-05-28 2018-11-19 Astrazeneca Ab Pharmaceutical composition which can be applied topically
US6822114B1 (en) 2002-10-08 2004-11-23 Albemarle Corporation Process for production of fluoroalkoxy-substituted benzamides and their intermediates
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
CN101969949B (en) * 2008-03-14 2013-12-25 大塚制药株式会社 MMP-2 and/or MMP-9 inhibitors
US11179384B2 (en) 2016-08-26 2021-11-23 Takeda Gmbh Treatment of nonalcoholic fatty liver disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK279958B6 (en) * 1992-04-02 1999-06-11 Smithkline Beecham Corporation PROTIALERGIC AND ANTI-INFLUENCE COMPOUNDS

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO0160358A1 *

Also Published As

Publication number Publication date
JP2004502643A (en) 2004-01-29
AU2001238288A1 (en) 2001-08-27
EP1261331A1 (en) 2002-12-04
WO2001060358A1 (en) 2001-08-23

Similar Documents

Publication Publication Date Title
DE60124302D1 (en) THIAZONE DERIVATIVES FOR THE TREATMENT OF PPAR-LIFE DISEASES
EP1324780A4 (en) METHODS OF TREATING HERZARRHYTHMIA
DE60023128D1 (en) PYRAZOLECARBOXAMIDE FOR THE TREATMENT OF FATIBILITY AND OTHER DISEASES
ATE417602T1 (en) AGENTS FOR THE TREATMENT OF DISEASES OF THE ESOPHAUS
DE60123238D1 (en) COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASES
DE60227095D1 (en) COMPOSITIONS AND METHODS FOR TREATING SEPARATED GIPS
DE60223694D1 (en) PLASTER FOR THE TREATMENT OF FUNCTIONAL DISORDERS AND FAILURES OF NAIL GROWTH
DE60138129D1 (en) APPARATUS FOR THE TREATMENT OF TEETH
DE60103137D1 (en) Vaccine for the treatment of atherosclerosis
ATE275145T1 (en) CHINAZOLINE DERIVATIVES FOR THE TREATMENT OF TUMORS
DE69918687D1 (en) 4-PHENYLPIPERIDINE FOR THE TREATMENT OF PRUTITIC SKIN DISEASES
DE60136477D1 (en) RETINOIDES FOR THE TREATMENT OF EMPHYSEM
DE60204466D1 (en) INTEGRINMA TREATMENT FOR THE TREATMENT OF EYE DISEASES
DE60136748D1 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES
DE50013843D1 (en) MEDICAMENT FOR THE TREATMENT OF DARMER DISEASES
DE60236743D1 (en) FOR THE TREATMENT OF ANDROGEN-DEPENDENT DISEASES
EP1506001A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF EPITHELLESION IN VAGINA, ZERVIX AND UTERUS
DE60016047D1 (en) DIHYDROBENZOPYRANE, DIHYDROBENZOTHIOPYRANE AND TETRAHYDROCHINOLINE FOR THE TREATMENT OF COX-2-DEPENDENT DISEASES
DE50105735D1 (en) CHLOROZAZAZONE FOR THE TREATMENT OF PSORIASIS
ATE273276T1 (en) CYCLOBUTENDIONE DERIVATIVES FOR THE TREATMENT OF ARTHEROSCLERosis
ATE443060T1 (en) BENZOAQUINOLINE DERIVATIVES FOR THE TREATMENT OF GLAUCOMA AND MIOPSIGHTEDNESS
DE60110748D1 (en) TREATMENT OF FLUOROEN CARBON FILLINGS
DE60103685D1 (en) Treatment of poriomania
DE69913380D1 (en) COMPOSITION FOR THE TREATMENT OF PERIODONTAL DISEASES
DE60203878D1 (en) METHOD FOR THE PREVENTION OF AND TREATMENT OF BOVINE PAIN AND STOMACH DISEASES

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020806

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20041124

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050614